Japan picking up on manufacturing outsourcing trend
Japan's market for contract manufacturing activities is predicted to double by 2009 as the outsourcing trend begins to take off in the country.
Archives for December 20, 2006
NNE scoops up Fresenius' Pharmaplan
NNE and Fresenius ProServe yesterday announced they had reached an agreement by which NNE will acquire Fresenius' subsidiary, engineering company Pharmaplan GmbH.
Fluidigm develops digital PCR technology
Fluidigm has launched its digital PCR technology, allowing scientists to analyse a single DNA template, which will give them the opportunity to detect cancer much earlier.
Monoclonal T cell receptors to be used for vaccine validation
German biotech company MediGene and Sanofi Pasteur have signed a deal to develop new monoclonal T cell receptors that the vaccine maker will use to develop and validate vaccines more efficiently.
How polo kinases split cells
Scientists have discovered how a key enzyme involved in cell division works, which could lead to more effective cancer treatments.
Ciphergen hires CRO for ovarian test trials
Ciphergen has hired contract research organization (CRO) PrecisionMed to help it with upcoming clinical trials for its experimental ovarian cancer tests.
A possible cure for diabetes
A breakthrough in diabetes research has finally let scientists answer the elusive question of what causes the disease, enabling them to develop to a new treatment that reverses its effects.
GSK sign world's-biggest licensing deal with Genmab
GlaxoSmithKline (GSK) has broken an industry record by licensing a drug for leukaemia from Genmab for $2.1bn (€1.6bn).
Bridge expand capabilities by acquiring Gene Logic unit
Bridge Pharmaceuticals has expanded its pre-clinical drug evaluation capabilities with the purchase of a division of Gene Logic for $15m
Injectable antipsychotic drug delivered by Captisol technology
Specialty pharmaceutical company CyDex has been boosted by the news that an intramuscular injection formulation of schizophrenia drug Abilify, which makes use of its Captisol solubility technology has been launched in the USA.
Wyeth kicks off CMO agreement with Crucell
Crucell yesterday announced it had received the first orders from US-headquartered Wyeth Biotech. The order represents the first move following the finalisation of the contract manufacturing agreement between the two companies at the end of 2005.
More speculation on inhaled insulin market potential
Innovative, non-invasive new ways of delivering insulin are poised to transform diabetes management, despite concerns about their safety and efficacy, according to new research.